Abstract:Background: RNA and microarray quality assessment form an integral part of gene expression analysis and, although methods such as the RNA integrity number (RIN) algorithm reliably asses RNA integrity, the relevance of RNA integrity in gene expression analysis as well as analysis methods to accommodate the possible effects of degradation requires further investigation. We investigated the relationship between RNA integrity and array quality on the commonly used Affymetrix Gene 1.0 ST array platform using reliable within-array and between-array quality assessment measures. The possibility of a transcript specific bias in the apparent effect of RNA degradation on the measured gene expression signal was evaluated after either excluding quality-flagged arrays or compensation for RNA degradation at different steps in the analysis. Results: Using probe-level and inter-array quality metrics to assess 34 Gene 1.0 ST array datasets derived from historical, paired tumour and normal primary colorectal cancer samples, 7 arrays (20.6%), with a mean sample RIN of 3.2 (SD = 0.42), were flagged during array quality assessment while 10 arrays from samples with RINs < 7 passed quality assessment, including one sample with a RIN < 3. We detected a transcript length bias in RNA degradation in only 5.8% of annotated transcript clusters (p-value 0.05, FC ≥ |2|), with longer and shorter than average transcripts under- and overrepresented in quality-flagged samples respectively. Applying compensatory measures for RNA degradation performed at least as well as excluding quality-flagged arrays, as judged by hierarchical clustering, gene expression analysis and Ingenuity Pathway Analysis; importantly, use of these compensatory measures had the significant benefit of enabling lower quality array data from irreplaceable clinical samples to be retained in downstream analyses. Conclusions: Here, we demonstrate an effective array-quality assessment strategy, which will allow the user to recognize lower quality arrays that can be included in the analysis once appropriate measures are applied to account for known or unknown sources of variation, such as array quality- and batch- effects, by implementing ComBat or Surrogate Variable Analysis. This approach of quality control and analysis will be especially useful for clinical samples with variable and low RNA qualities, with RIN scores ≥ 2.

An analysis of RNA quality metrics in human brain tissue

The influence of tissue pH and RNA integrity number on gene expression of human postmortem brain

Quality assessment and control of tissue specific RNA-seq libraries of Drosophila transgenic RNAi models

mRIN for direct assessment of genome-wide and gene-specific mRNA integrity from large-scale RNA-sequencing data

Precision and Accuracy of Single-Cell/Nuclei RNA Sequencing Data

Quality assessment and data handling methods for Affymetrix Gene 1.0 ST arrays with variable RNA integrity

Variation of Peripheral Blood Mononuclear Cell RNA Quality in Archived Samples

Measure Transcript Integrity Using RNA-seq Data

Sequencing Degraded RNA Addressed by 3' Tag Counting

Characterizing cell type specific transcriptional differences between the living and postmortem human brain

Effects of brain tissue section processing and storage time on gene expression

Optimized Method for Robust Transcriptome Profiling of Minute Tissues Using Laser Capture Microdissection and Low-Input RNA-Seq

Evaluating the Comparability of Gene Expression in Blood and Brain

Quantitative Analysis of Noncoding RNA from Paired Fresh and Formalin-Fixed Paraffin-Embedded Brain Tissues

The spatial RNA integrity number assay for in situ evaluation of transcriptome quality

Assessing methylation detection for primary human tissue using Nanopore sequencing

Impact of RNA Integrity and Blood Sample Storage Conditions on the Gene Expression Analysis

Integrity assay for messenger RNA in mouse and human brain samples and synaptosomal preparations

Isoform-level profiling of m6A epitranscriptomic signatures in human brain

Distinctive RNA Expression Profiles in Blood Associated with Alzheimer Disease after Accounting for White Matter Hyperintensities.

Mapping medically relevant RNA isoform diversity in the aged human frontal cortex with deep long-read RNA-seq